Clinical

Dataset Information

0

Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer


ABSTRACT: This phase II trial studies how well Linifanib works in treating patients with advanced, refractory colorectal cancer expressing k-Ras mutations. Linifanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

DISEASE(S): Stage Ivb Colon Cancer,Recurrent Colon Cancer,Rectal Neoplasms,Stage Iva Rectal Cancer,Stage Ivb Rectal Cancer,Recurrent Rectal Cancer,Stage Iva Colon Cancer,Colonic Neoplasms

PROVIDER: 2107600 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2099626 | ecrin-mdr-crc
| 2100536 | ecrin-mdr-crc
| 2097388 | ecrin-mdr-crc
| 2177542 | ecrin-mdr-crc
| 2301091 | ecrin-mdr-crc
| 2091768 | ecrin-mdr-crc
| 2088598 | ecrin-mdr-crc
| 2038559 | ecrin-mdr-crc
| 2010182 | ecrin-mdr-crc
| 2229983 | ecrin-mdr-crc